AEON

AEON Biopharma, Inc.

1.41 USD
-0.09 (-6.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

AEON Biopharma, Inc. stock is down -63.38% since 30 days ago. The next earnings date is Aug 11, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 May’s closed higher than April. 100% of analysts rate it a buy.

About AEON Biopharma, Inc.

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.

  • HC Wainwright & Co.
    Thu May 30, 07:25
    buy
    confirm
  • HC Wainwright & Co.
    Wed May 15, 14:02
    buy
    confirm
  • HC Wainwright & Co.
    Mon May 6, 06:43
    buy
    confirm